• ZiP Diagnostics

$600,000 federal grant for quick 30 minute COVID-19 test


Australian owned and Melbourne based biotech company ZiP Diagnostics (ZiP) has received a $600,000 grant from the Federal Government to develop a new and extremely quick point-of-care test for COVID-19

Federal Minister for Health, the Hon Greg Hunt, made the announcement, revealing details of the third round of grants from the $45 million BioMedTech Horizons (BMTH) program, an initiative of the Medical Research Future Fund operated by MTPConnect.

The grant will allow the company to begin manufacturing and marketing its low cost and easy to use diagnostic test system that delivers a result in less than 30 minutes.

The unit is extremely mobile and can undertake hundreds of tests per hour It provides sensitivity comparable to the polymerase chain reaction (PCR) gold standard and can be used at community level without the need for a medical testing laboratory or technician.

Apart from COVID-19, the ZiP system also tests for sexually transmitted infections and other infections of global importance.

The portable test instrumentation can be quickly deployed to any location to maximise impact on COVID-19 identification and containment and is scalable from small volumes to thousands of tests in a day.

The BMTH grant will greatly assist with development and regulatory approval of ZiP’s world leading molecular diagnostic technology.

“We are delighted to receive this BMTH grant as it provides valuable funding for the development of ZiP’s technology and will allow us to secure regulatory approval in a shorter time frame than originally envisaged,” said ZiP Technical Director Bill Hopper.

“It will also allow Australia to supply low-middle income countries — who have desperately pressing needs in medical diagnostics and antibiotic stewardship — to assist with disease elimination.”

ZiP Diagnostics was launched in 2019 to meet global infectious diseases testing challenges and provide pandemic protection for Australia.

All key elements of the ZiP technology are made locally ensuring Australia is less susceptible to global supply chain issues for diagnostic equipment.

The test regime is suitable for use across many industry and community sectors including government, health, travel, defence, education, mining, industrial, commercial and sport.

“This innovative technology and our local production capacity means ZiP is ideally placed to play a major role in the identification, containment and management of COVID-19 in Australia,” Mr Hopper said.

All_Issues_Banner-01.jpg
Today's Local News
1232 Live Music Lake Mac InTouch 300x300
4563-Reset_summer_social tile_300x300.jp
JobQuest-Online.gif
intouch THIS MONTH

ABOUT INTOUCH MAGAZINE

Every month intouch magazine captures the unique spirit of our region and grabs the attention of the community. Intouch magazine showcases what’s hot, what’s on and who’s who with a dynamic blend of inspirational articles, lifestyle features, fashion, events, food and travel – it’s the go-to source for people living in (or visiting) Newcastle, Lake Macquarie, Port Stephens and The Hunter Valley. It’s the place to be seen to build your reputation, tell your story, launch a new enterprise and keep the community intouch both in print and online.

CONTACT US

QUICK LINKS

297 Brunker Rd, Adamstown NSW 2289 

PO BOX 165, CHARLESTOWN NSW 2290

PH +61 2 4943 0888 

EMAIL US

subscribe to  intouch

Copyright 2015-2020 Two Tribes Media. Published monthly by Two Tribes Media. All rights reserved. Permission to reprint or quote excerpt granted by written request only. While every attempt has been made, Two Tribes media cannot guarantee the legality, completeness or accuracy of the information presented and accepts no warranty or responsibility for such.

© 2015-2020 Two Tribes Media